Molecular size of dermatan sulfate oligosaccharides required to bind and activate heparin cofactor II.

作者: D M Tollefsen , M E Peacock , W J Monafo

DOI: 10.1016/S0021-9258(19)84460-5

关键词:

摘要: Heparin cofactor II (HCII) inhibits thrombin rapidly in human plasma the presence of heparin or dermatan sulfate. To determine minimum structure sulfate required to activate HCII, glycosaminoglycan was partially degraded by sequential treatment with periodate, [3H]borohydride, and sulfuric acid. Labeled oligosaccharide fragments were separated gel filtration chromatography. Purified then applied a column HCII bound concanavalin A-Sepharose, oligosaccharides eluted gradient sodium chloride. Di-, tetra-, hexasaccharide did not bind while 15% octasaccharides up 45% larger bound. Octasaccharides that had greater negative charge than run-through material based on anion-exchange chromatography, suggesting they contained number groups per molecule. Fragments containing 12-14 sugar residues accelerated inhibition HCII. this length immobilized molar specific activities those bind. These studies suggest is activated equal 12 contain octasaccharide sequence for binding inhibitor.

参考文章(30)
Lars-Åke Fransson, Lars Cöster, Birgitta Havsmark, Anders Malmström, Ingrid Sjöberg, The copolymeric structure of pig skin dermatan sulphate. Isolation and characterization of L-idurono-sulphate-containing oligosaccharides from copolymeric chains. Biochemical Journal. ,vol. 143, pp. 379- 389 ,(1974) , 10.1042/BJ1430379
U Lindahl, G Bäckström, L Thunberg, The antithrombin-binding sequence in heparin. Identification of an essential 6-O-sulfate group. Journal of Biological Chemistry. ,vol. 258, pp. 9826- 9830 ,(1983) , 10.1016/S0021-9258(17)44572-8
George F. Briginshaw, J.N. Shanberge, Identification of two distinct heparin cofactors in human plasma Archives of Biochemistry and Biophysics. ,vol. 161, pp. 683- 690 ,(1974) , 10.1016/0003-9861(74)90354-3
M J Griffith, C M Noyes, F C Church, Reactive site peptide structural similarity between heparin cofactor II and antithrombin III. Journal of Biological Chemistry. ,vol. 260, pp. 2218- 2225 ,(1985) , 10.1016/S0021-9258(18)89541-2
D M Tollefsen, C A Pestka, W J Monafo, Activation of heparin cofactor II by dermatan sulfate. Journal of Biological Chemistry. ,vol. 258, pp. 6713- 6716 ,(1983) , 10.1016/S0021-9258(18)32276-2
D M Tollefsen, D W Majerus, M K Blank, Heparin cofactor II. Purification and properties of a heparin-dependent inhibitor of thrombin in human plasma. Journal of Biological Chemistry. ,vol. 257, pp. 2162- 2169 ,(1982) , 10.1016/S0021-9258(18)34900-7
H Saito, T Yamagata, S Suzuki, Enzymatic Methods for the Determination of Small Quantities of Isomeric Chondroitin Sulfates Journal of Biological Chemistry. ,vol. 243, pp. 1536- 1542 ,(1968) , 10.1016/S0021-9258(18)93575-1
J Riesenfeld, L Thunberg, M Höök, U Lindahl, None, The antithrombin-binding sequence of heparin. Location of essential N-sulfate groups. Journal of Biological Chemistry. ,vol. 256, pp. 2389- 2394 ,(1981) , 10.1016/S0021-9258(19)69792-9
Michael J. Griffith, Claudia M. Noyes, Jo Ann Tyndall, Frank C. Church, Structural evidence for leucine at the reactive site of heparin cofactor II Biochemistry. ,vol. 24, pp. 6777- 6782 ,(1985) , 10.1021/BI00345A008